Recombinant ALK (Anaplastic Lymphoma Kinase) / CD246 Antibody, Clone: [ALK1/6698R], Rabbit, Monoclonal

Produktübersicht

• Artikelname: Recombinant ALK (Anaplastic Lymphoma Kinase) / CD246 Antibody, Clone: [ALK1/6698R], Rabbit, Monoclonal
• Artikelnummer: NBT-238-RBM8-P1
• Hersteller Artikelnummer: 238-RBM8-P1
• Alternativnummer: NBT-238-RBM8-P1-100
• Hersteller: NeoBiotechnologies
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: IHC
• Spezies Reaktivität: Human
• Immunogen: Recombinant human ALK protein fragment around aa 1058-1620 (exact sequence is proprietary)
• Alternative Synonym: ALK/NPM1 fusion gene, Anaplastic lymphoma kinase Ki1, Anaplastic Lymphoma Kinase p80, anaplastic lymphoma receptor tyrosine kinase, mutant anaplastic lymphoma kinase, NBLST3, Tcrz, TFG/ALK

Produktbeschreibung

Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase of the insulin receptor superfamily. ALK is typically expressed at low levels in regions of the developing central and peripheral nervous system. ALK may be activated in cancer through multip

Produkteigenschaften

• Klonalität: Monoclonal
• Klon-Bezeichnung: [ALK1/6698R]
• Molekulargewicht: 177kDa
• NCBI: 238
• UniProt: Q9UM73
• Formulierung: 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Bilder

Formalin-fixed, paraffin-embedded human inflamma